(Q36787468)

16 August 2017

1 reference

title

Current trends in migraine prophylaxis (English)

1 reference

16 August 2017

1 reference

Nabih M Ramadan

1

1 reference

16 August 2017

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

47 Suppl 1

1 reference

16 August 2017

page(s)

S52-7

1 reference

Prophylactic pharmacotherapy for migraine headaches

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Contemporary concepts of migraine pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Migraine: imaging the aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Calcium channels in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Calcium channels and channelopathies of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

An evaluation of intrathecal ziconotide for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Spreading depression: imaging and blockade in the rat neocortical brain slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Chronic daily headache: a scientist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Olanzapine in the treatment of refractory migraine and chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Petasites hybridus root (butterbur) is an effective preventive treatment for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2007.00677.X

10.1111/J.1526-4610.2007.00677.X

21 January 2018

Identifiers

DOI

1 reference

release_kdfbucyh7bchnhf35byf7ftg5u

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kdfbucyh7bchnhf35byf7ftg5u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference